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A B S T R A C T
Objective: To evaluate the metabolic correlates of lifetime sport practice in ALS through brain 18F-FDG-PET.
Methods: 131 patients completed a questionnaire about lifetime exposures, including physical activity related to
sports, hobbies and occupations, and underwent brain 18F-FDG-PET. Exposure to sports was expressed as MET
(Metabolic Equivalent of Task). We considered only regular practice (at least 2 h/week, for at least three
months). We compared brain metabolism between two groups: subjects who did not report regular sport practice
during life (N-group) and patients who did (Y-group). The resulting significant clusters were used in each group
as seed regions in an interregional correlation analysis (IRCA) to evaluate the impact of lifetime sport practice on
brain networks typically involved by the neurodegenerative process of ALS. Each group was compared to healthy
controls (HC, n = 40).
Results: We found a significant, relative cerebellar hypermetabolism in the N-group compared to the Y-group.
The metabolism of such cerebellar cluster resulted correlated to more significant and widespread metabolic
changes in areas known to be affected by ALS (i.e. frontotemporal regions and corticospinal tracts) in the N-
group as compared to the Y-group, despite the same level of disability as expressed by the ALS FRS-R. Such
findings resulted independent of age, sex, site of onset (bulbar/spinal), presence/absence of C9ORF72 expansion,
cognitive status and physical activity related to hobbies and occupations. When compared to HC, the N-group
showed more widespread metabolic changes than the Y-group in cortical regions known to be relatively hy-
pometabolic in ALS patients as compared to HC.
Conclusions: We hypothesize that patients of the N-group might cope better with the neurodegenerative process,
since they show more widespread metabolic changes as compared to the Y-group, despite the same level of
disability. Nevertheless, further studies are necessary to corroborate this hypothesis.
1. Introduction
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease
affecting motor neurons, leading to death within approximately three
years, usually due to respiratory failure (van Es et al., 2017). Herit-
ability studies suggest that genetic factors account for approximately
60% of the risk of developing ALS, while the remaining 40% is due to
environmental exposures (Al-Chalabi and Hardiman, 2013). The
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possible impact of lifetime physical activity (PA) on the risk of devel-
oping ALS has been investigated, since vigorous physical exercise might
cause oxidative stress and glutamate excitotoxicity (Bastos et al., 2011;
Harwood et al., 2009). Nevertheless, published studies about cumula-
tive, leisure and occupational PA as a risk factor are inconclusive
(Lacorte et al., 2016). The reasons of such heterogeneity of results in-
clude differences in PA quantification and study design, the difficulty of
evaluating a single environmental factor among the others, the varia-
bility of exposures in space and time, and possible gene-environment
interactions. A detrimental role of sport practice on the risk of ALS has
been hypothesized by studies on former athletes, including Italian
professional soccer players (Chiò et al., 2005) and American football
players (Lehman et al., 2012). A recent multicentre, cross-cultural,
population-based, case-control study performed in the context of the
Euro-MOTOR Project showed a linear association between lifetime PA
and the risk of ALS, that was independent of age, sex, education,
smoking and alcohol. A detrimental effect was found for leisure activ-
ities (sports and hobbies), occupational activities and for all activities
combined (Visser et al., 2018). We focused on the metabolic correlates,
assessed through brain 18F-2-fluoro-2-deoxy-D-glucose-PET (18F-FDG-
PET), of lifetime sport practice in a subset of the population-based ALS
series recruited in Piedmont and Valle d’Aosta, Italy, in the context of
the Euro-MOTOR Project.
2. Methods
2.1. Partecipants recruitment
The Euro-MOTOR Project was a multicentre, case-control, European
study involving the Netherlands, Italy (Piedmont and Valle d’Aosta,
Lombardy and Apulia regions) and Ireland, including incident cases
diagnosed with definite, (laboratory-supported) probable or possible
ALS according to the El Escorial revised criteria (Brooks et al., 2000)
from February 2011 to February 2014 (D’Ovidio et al., 2017). A
structured questionnaire was administered to 1557 patients and 2922
controls in order to collect exposome data about PA (sports, hobbies,
occupations), and many other factors, including traumas and pharma-
cological therapies. At the ALS Centre of Turin, Piedmont, Italy, 262
patients were enrolled in the Euro-MOTOR Project. Of these, 131 (50%)
underwent brain 18F-FDG-PET at diagnosis, in the context of the re-
search activity of our Centre about the metabolic correlates of neuro-
degeneration in ALS (Pagani et al., 2016; Cistaro et al., 2014), and were
included in the present study. The other cases of the Euro-MOTOR
sample did not undergo 18F-FDG-PET for the following reasons: denial,
orthopnoea or difficulties reaching the PET Centre.
Forty subjects who were referred to the PET Centre for a suspected
diagnosis of lung cancer in whom no oncologic disease was disclosed
with 18F-FDG-PET/CT and who had a normal neurological assessment
served as controls. Exclusion criteria were presence of major systemic
illness, major vision disturbances, psychiatric illnesses, and diseases
affecting brain functioning and metabolism.
2.2. Assessment of lifetime sport practice
Patients were interviewed through a structured questionnaire in-
cluding many exposome aspects, as mentioned above, so limiting recall
bias as much as possible. To quantify the lifetime exposure to PA, the
Euro-MOTOR Project employed the Compendium of Physical Activities
(Ainsworth et al., 2000). Such tool allows to estimate the metabolic
consumption for each PA, calculated as the ratio to a standard resting
condition (sitting quietly). The energy expenditure is expressed as MET
(Metabolic Equivalent of Task): 1 MET corresponds to 1 Kcal/Kg body
weight/h. The following formula was used to calculate the lifetime
scores per participant, where k represents a specific PA:
× ×= (MET score duration in years hours per week )k 1n k k k
In the Euro-MOTOR Project such methodology allowed to quantify
PA related to sport activities, hobbies and occupations with three dis-
tinct scores. All exposures were calculated up to 3 years before the
enrolment in the survey, since over 95% of all participants of the Euro-
MOTOR Study had a delay from disease onset to survey of< 3 years
(D’Ovidio et al., 2017). We considered only regular sport practice, i.e.
physical exercise for at least 2 h per week, for at least three months.
Patients were then classified into two groups: subjects who had never
practiced sport regularly during their life (NO sport practice, i.e. N-
group, for whom MET score related to sport was 0, n = 78), and those
who had practiced sport regularly, regardless of the entity of the ex-
posure (YES sport practice, i.e. Y-group, for whom MET score related to
sports was > 0, n = 53).
2.3. 18F-FDG-PET acquisition
18F-FDG-PET was performed according to published guidelines
(Varrone et al., 2009). Briefly, subjects fasted at least six hours before
the exam. Blood glucose was < 7.2 mmol/l in all cases before the
procedure. After a 20-minute rest, about 185 MBq of 18F-FDG were
injected. The acquisition started 60 min after the injection. PET/CT
scans were performed by a Discovery ST-E System (General Electric).
Brain CT (thickness of 3.75 mm, 140 kVolt, 60–80 mAs) and PET scan
(1 FOV of 30 transaxial centimetres) were sequentially acquired, being
the former used for attenuation correction of PET data. Data were
collected in 128 × 128 matrices with a reconstructed voxel of
2.34 × 2.34 × 2.00 mm.
2.4. Statistical analysis
Demographic and clinical characteristics and exposome data of the
N-group and the Y-group were compared through Mann-Whitney and
χ2 tests where applicable. Demographic characteristics of patient
groups and healthy controls were compared through Mann-Whitney
and χ2 tests where applicable. SPM8 implemented in Matlab 7.10.0
(MathWorks) was used for image normalization. A customized brain
18F-FDG-PET template, obtained from scans performed at the same
centre, was utilized for spatial normalization. Intensity normalization
was performed using the 0.8 default SPM value of grey matter threshold
and images were subsequently smoothed with an 8-mm filter and
submitted to statistical analysis. The 18F-FDG-PET data of the two
groups were compared applying the two-sample t-test of SPM12, in-
cluding age at PET, sex, site of onset (spinal/bulbar), presence/absence
of C9ORF72 expansion, ALS FRS-R (ALS Functional Rating Scale-
Revised) total score at the time of PET, MET score related to hobbies
and MET score related to occupational activities as covariates. The
height threshold was set at p < 0.01uncorrected, p < 0.05FWE-corrected at
cluster level. Only clusters containing at least 100 contiguous voxels
have been considered significant. Metabolic clusters showing a sig-
nificant difference between the two groups were then used as seed re-
gions in a multiple regression analysis for each group to identify cerebral
regions whose metabolism was positively or negatively correlated with
that of the seed clusters (i.e interregional correlation analysis, IRCA)
(Morbelli et al., 2013). In the IRCA the height threshold was set at
p < 0.005uncorrected; p < 0.05FWE-corrected at cluster level.
Then, each patient group (i.e. N-group and Y-group) was compared
to healthy controls, setting the height threshold at p < 0.05FWE-corrected;
p < 0.05FWE-corrected at cluster level.
Brodmann areas (BAs) were identified at a 0–2 mm range from the
Talairach coordinates of the SPM output isocentres corrected by
Talairach Client (http://www.talairach.org/index.html).
Since the neuropsychological assessment was not available for 14
subjects out of 131, we performed a sensitivity analysis on the
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remaining 117 patients: we repeated the comparison between the N-
group and the Y-group adding the cognitive status to the covariates
mentioned above. The neuropsychological battery and the testing pro-
cedure have been previously described (Montuschi et al., 2015). Based
on the performance at the neuropsychological assessment, the cognitive
status was classified as normal, frontotemporal dementia (FTD) and
intermediate impairment (i.e. patients with cognitive and/or beha-
vioural impairment not fulfilling criteria for full-blown FTD) according
to published criteria (Strong et al., 2009).
2.5. Ethical issues
This work has been carried out in accordance with the Code of
Ethics of the World Medical Association (Declaration of Helsinki) and
with Uniform Requirements for manuscripts submitted to Biomedical
Journals. The study has been approved by the ethical committee
“Comitato Etico Interaziendale Azienda Ospedaliero-Universitaria Città
della Salute e della Scienza di Torino”. Patients signed a written in-
formed consent.
2.6. Data availability statement
Data will be available upon request by interested researchers.
3. Results
3.1. Demographic and clinical characteristics and exposome data
A descriptive summary statistics of covariates stratified by sport
practice (N-group versus Y-group) is reported in Table 1. We found a
prevalence of males in the group who practiced sport (p = 0.001). The
age at PET was lower in the Y-group as compared to the N-group
(p < 0.05). No significant difference was found for site of onset
(bulbar/spinal), presence/absence of C9ORF72 expansion, ALS FRS-R
total score at the time of PET, MET score related to lifetime hobbies and
MET score related to occupational activities.
When considering only patients for whom the neuropsychological
assessment was available (n = 117), the difference of cognitive status
was not significant between N- and Y-group (p = 0.07; Table 2).
Table 2 reports no difference between the two groups in terms of pre-
vious general and head traumas and exposure to drugs related to sport
practice (the list of drugs is reported in Inline Supplementary Table 1).
Sex and age at PET were included among covariates in the com-
parison between N-group and Y-group, while cognitive status was
considered as covariate in the sensitivity analysis.
The control group (n = 40) showed median age at PET of 66.5 years
(interquartile range 55–72), and male/female ratio of 2.64 (29/11). As
compared to the control group, the N-group did not show any sig-
nificant difference of age at PET (p = 0.172), while the male/female
ratio was significantly lower in the N-group (p = 0.004). As compared
to the control group, the Y-group did not show any significant differ-
ence of age at PET (p = 0.592) and male/female ratio (p = 0.907).
Anyway, both age at PET and sex were included among covariates in
the comparisons between each patient group and healthy controls.
3.2. 18F-FDG-PET
We did not find any region of relative hypometabolism in the N-
group compared to the Y-group.
The N-group showed relative hypermetabolism compared to the Y-
group in the cerebellum bilaterally (Fig. 1, Table 3).
The sensitivity analysis showed substantially unchanged findings
(data not shown).
The IRCA showed that in the N-group metabolism in such cerebellar
cluster negatively correlated with metabolism in left medial and in-
ferior frontal gyrus, insula, superior, transverse and middle temporal
gyrus and in bilateral superior and middle frontal gyrus (Fig. 2A,
Table 4). In the Y-group the metabolism in this cerebellar cluster was
negatively correlated with metabolism in smaller clusters including
bilateral cingulate gyrus and right superior and middle frontal gyrus
Table 1
Descriptive summary statistics of covariates, stratified by sport activity (N-
group versus Y-group).
Sport activity Total p*
N-group Y-group
Sex
Female (%) 43 (55.1) 14 (26.4) 57 (43.5) p = 0.001
Male (%) 35 (44.9) 39 (73.6) 74 (56.5)
Age, median (IQR) 67.5
(60.7–73.6)
62.2
(51.8–70.6)
67
(58.3–72.8)
p < 0.05
Site of onset
Bulbar (%) 35 (44.9) 16 (30.2) 51 (38.9) p = 0.091
Spinal (%) 43 (55.1) 37 (69.8) 80 (61.1)
C9ORF72
expansion (%)
11 (14.1) 5 (9.4) 16 (12.2) p = 0.423
Total Occupation
MET scores,
median (IQR)
3975
(2524–5775)
3036
(2229–4860)
3800
(2394–5670)
p = 0.159
Total Hobby MET
scores, median
(IQR)
425
(148–1210)
365
(60–1237)
396
(96–1237)
p = 0.449
Total ALS FRS-R
score, median
(IQR)
39 (36–43) 41 (37–45) 40 (36–44) p = 0.346
Total 78 (1 0 0) 53 (1 0 0) 131 (1 0 0)
Significant differences are reported in bold. IQR, Interquartile Range; ALS FRS-
R, ALS Functional Rating Scale-Revised.
* Mann-Whitney test and Chi-square test were performed for continuous and
discrete variables respectively.
Table 2
Descriptive summary statistics of cognitive status, history of general and head
traumas, and intake of sport-related drugs, stratified by sport activity (N-group
versus Y-group).
Sport activity Total p*
N-group Y-group
Cognitive status
Normal (%) 32 (47.1) 32 (65.3) 64 (54.7) p = 0.070
Intermediate (%) 21 (30.8) 13 (26.5) 34 (29.1)
FTD (%) 15 (22.1) 4 (8.2) 19 (16.2)
missing 10 4 14
General traumas
No (%) 21 (26.9) 8 (15.1) 29 (22.1) p = 0.109
Yes (%) 57 (73.1) 45 (84.9) 102 (77.9)
Head traumas
No (%) 54 (69.2) 36 (67.9) 90 (68.7) p = 0.874
Yes (%) 24 (30.8) 17 (32.1) 41 (31.3)
Sport-related drugs
No (%) 68 (87.2) 47 (88.7) 115 (87.8) p = 0.797
Yes (%) 10 (12.8) 6 (11.3) 16 (12.2)
Total 78 (1 0 0) 53 (1 0 0) 131 (1 0 0)
* Mann-Whitney test and Chi-square test were performed for continuous and
discrete variables respectively.
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(Fig. 2B, Table 5). The metabolism of the cerebellar cluster showed a
positive correlation in both groups with the metabolism in corticospinal
tracts, that was larger in the N-group (Fig. 2C) as compared to the Y-
group (Fig. 2D).
The comparison between the N-group and healthy controls revealed
a relative hypometabolism in the N-group in clusters including bilateral
precentral gyrus, left middle frontal gyrus, left lingual gyrus, left in-
ferior occipital gyrus, right angular gyrus, and bilateral cuneus (see
Inline Supplementary Figure 1 and Inline Supplementary Table 2). No
areas of relative hypermetabolism in the N-group were found.
The comparison between the Y-group and healthy controls revealed
a relative hypometabolism in the Y-group in the cuneus bilaterally (see
Inline Supplementary Figure 2 and Inline Supplementary Table 3). No
areas of relative hypermetabolism in the Y-group were found.
4. Discussion
In the present study we compared the brain metabolic pattern, as
assessed through 18F-FDG-PET, of two groups of ALS patients, i.e.
subjects who had never practiced sports regularly during their life (N-
group), and subjects who practiced sport activities regularly, with dif-
ferent entity of exposure (Y-group). We found a significant, relative
cerebellar hypermetabolism in the N-group as compared to the Y-group.
The metabolism of the cerebellar cluster showed a negative correlation
with metabolism of frontotemporal regions that resulted more sig-
nificant and more widespread in the N-group as compared to the Y-
group. Furthermore, the metabolism of the same cerebellar cluster
showed a positive correlation with the metabolism of the corticospinal
tracts in both groups, with a larger size of the cluster in the N-group.
Such findings resulted independent of age at 18F-FDG-PET, sex, site of
onset (bulbar/spinal), presence/absence of C9ORF72 expansion, level
of disability as assessed by ALS FRS-R total score, cognitive status and
PA related to hobbies and occupations. Furthermore, when compared to
healthy controls, the N-group showed more widespread cortical meta-
bolic changes than the Y-group.
The finding of a cerebellar relative hypermetabolism has been al-
ready reported in ALS patients as compared to healthy controls (D’hulst
et al., 2018). Furthermore, a study evaluating the brain metabolic
correlates at 18F-FDG-PET of the different degrees of cognitive impair-
ment in ALS reported a decreasing gradient of frontal lobe metabolism
from cognitively spared patients to subjects with frontotemporal de-
mentia (FTD), while patients with mild cognitive deficits showed an
intermediate metabolic behaviour. Strikingly, frontal lobe relative hy-
pometabolism resulted associated with relative hypermetabolism in
cerebellum, corticospinal tracts and midbrain, with increasing statis-
tical significance and cluster size as the cognitive impairment increased
(Canosa et al., 2016).
To interpret our finding of a cerebellar, relative hypermetabolism in
the N-group, we employed the identified cerebellar cluster as seed re-
gion to evaluate which brain regions showed a positive or negative
correlation of metabolism (i.e. interregional correlation analysis, IRCA).
In the N-group cerebellar metabolism resulted negatively correlated
with metabolism in bilateral frontal and left temporal regions. In the Y-
group cerebellar metabolism was negatively correlated with bilateral
cingulate cortex and right superior and middle frontal gyrus.
Furthermore, we observed a positive correlation between the metabo-
lism of the cerebellar cluster of interest and that of corticospinal tracts
in both N- and Y-group, that resulted more extensive in the N-group.
Indeed, relative hypermetabolism at 18F-FDG-PET of corticospinal
tracts has been already reported in ALS and has been usually ascribed to
gliosis due to motor axons degeneration (Chiò et al., 2014). Based on
the larger size and the higher statistical significance of the fronto-
temporal clusters of negative correlation and the more extensive posi-
tive correlation with the corticospinal tracts detected in the N-group in
the IRCA, we hypothesize that in the N-group the relative, cerebellar
hypermetabolism is related to lower metabolic levels in frontotemporal
regions and higher metabolic levels in corticospinal tracts, both pos-
sibly due to a more severe neurodegenerative process in areas already
known to be involved in ALS (Pagani et al., 2014; Van Laere et al.,
2014). The cerebellum is known to be involved in both motor and extra-
motor function (Reeber et al., 2013). Its role in ALS has been
Fig. 1. Glass brain rendering of the comparison between the N-group and the Y-
group. The clusters showing a statistically significant, relative hypermetabolism
in the N-group as compared to the Y-group are projected on brain surface. N-
group: NO sport practice. Y-group: YES sport practice.
Table 3
Regions of relative hypermetabolism in the N-group as compared to the Y-group. N-group: NO sport practice. Y-group: YES sport practice.
P (FWEcorrected) Cluster extent Z-score Talairach coordinates Cluster site
0.001 1779 3.76 −34 −74 −40 Left Cerebellum Posterior Lobe - Inferior Semi-Lunar Lobule
3.67 −10 −50 −26 Left Cerebellum Anterior Lobe - Dentate
3.58 −12 −45 −40 Left Cerebellum Posterior Lobe - Cerebellar Tonsil
0.025 947 3.59 26 −72 −40 Right Cerebellum Posterior Lobe - Inferior Semi-Lunar Lobule
3.35 8 −56 −26 Right Cerebellum Anterior Lobe - Dentate
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investigated in different studies, with conflicting results. A study in-
cluding MRI longitudinal assessment of ALS and PLS patients has shown
significant white matter damage over time in different regions, in-
cluding the cerebellum (Menke et al., 2018). Otherwise, a recent mul-
timodal MRI study has reported significantly decreased grey matter
volume (GMV) in the left precentral gyrus, increased GMV in bilateral
cerebellum, and decreased functional connectivity in the cerebellar
anterior lobe in patients with ALS compared with healthy controls. The
authors interpreted their findings as evidence of precentral degenera-
tion and cerebellar compensation in ALS, suggesting that the white
matter alterations mediate the relationship between the pathologies of
the primary motor cortex and the cerebellum (Qiu et al., 2019). A
possible explanation of such discrepancy has been hypothesized in a
recent functional MRI study showing the coexistence of cerebellar cir-
cuits with decreased and increased connectivity, suggesting the con-
comitance of neurodegenerative and adaptive changes (Abidi et al.,
2020).
Being the ALS FRS-R a score quantifying disability and functional
impairment in ALS (Cedarbaum and Stambler, 1997), it can be con-
sidered as a measure of motor performance, albeit not accurate. So, we
included it as a covariate in the analyses. Based on the results of the
IRCA, we could hypothesize that N-patients can cope better with the
neurodegenerative process due to ALS as compared to Y-patients, at the
same level of disability as expressed by the ALS FRS-R score. Accord-
ingly, when compared to healthy controls, the N-group showed more
widespread metabolic changes than the Y-group in cortical regions
known to be relatively hypometabolic in ALS patients as compared to
healthy controls (Pagani et al., 2014), suggesting the presence of larger
ALS-related brain metabolic changes in the N-group as compared to the
Y-group, although the same level of motor disability.
Based on our results, we speculate that subjects who have never
practiced sports are able to cope better with the neurodegenerative
process. Since our patients underwent brain 18F-FDG-PET at diagnosis,
the relative cerebellar hypermetabolism found in our study might re-
present an early adaptive mechanism to degeneration of frontotemporal
regions and corticospinal tracts, probably destined to be overcome by
Fig. 2. Results of the IRCA in the N-group, showing clusters of negative (A) and positive (C) correlation with metabolism of the cerebellar cluster of interest. Results
of the IRCA in the Y-group, showing clusters of negative (B) and positive (D) correlation with metabolism of the cerebellar cluster of interest. N-group: NO sport
practice. Y-group: YES sport practice.
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neurodegeneration over time. If this resilience may be due to the pre-
servation of compensatory mechanisms and/or brain reserve that can
be exhausted by sport practice, can be subject to discussion. Indeed, this
hypothesis could agree with the report of a lower age at ALS onset in
professional athletes (Chiò et al., 2005). In this context, further aspects
should be considered. Some studies suggest that subjects with relatively
higher levels of cardiovascular (Turner et al., 2012) and physical
(Mattsson et al., 2012) fitness show a higher risk of ALS. It is possible
that PA is not a risk factor for ALS per se, but rather that a genetic
profile promoting fitness also leads to increased ALS susceptibility
(Huisman et al., 2013; Chiò and Mora, 2012), or that PA anticipates the
occurrence of the disease in genetically predisposed individuals
(Hamidou et al., 2014).
Nevertheless, this field needs further studies, overcoming the lim-
itations of the present one. First, although the ALS FRS-R is a validated
measure of disability caused by ALS, its total score does not provide an
accurate estimation of motor performance. For such purpose the
Walking Test or prolonged actigraphic registration may be possible
tools. Second, the information resulting from 18F-FDG-PET, a valuable
marker of neurodegeneration in vivo (Jack et al., 2012), might be
complemented by the different brain MRI techniques (voxel-based
morphometry, diffusion tensor imaging, resting state imaging) and
spinal cord MRI. Third, the use of MET to quantify PA does not take into
account differences among persons in body mass, body fat percentage,
age, cardiorespiratory fitness levels, and can be inaccurate in measuring
activities performed in different environmental conditions (Ainsworth
et al., 2000). Anyway, albeit not free from limitations, the use of MET is
suggested as a valuable tool to quantify lifetime exposure to PA (Lacorte
et al., 2016). Fourth, the classification of patients into two groups, i.e.
N- and Y-group, does not consider the different entity of the exposure to
sport practice. We tried to subdivide the Y-group in tertiles or into two
groups according to the median value of MET scores related to sport
practice (above median value and below median value). The compar-
isons between each subgroup of the Y-group and the N-group provided
a trend towards results overlapping those obtained comparing the
whole Y-group and the N- group, but not reaching statistical sig-
nificance probably due to the reduced size of the subgroups. Further-
more, we performed a multiple regression analysis in the Y-group to
evaluate the relationship between brain metabolism and MET scores
related to sport practice, but we did not find any significant cluster
Table 4
Results of the IRCA in the N-group: regions whose metabolism resulted negatively correlated with that of the cerebellar cluster of interest. IRCA: interregional
correlation analysis. N-group: NO sport practice. BA: Brodmann Area.
P (FWEcorrected) Cluster extent Z-score Talairach Coordinates Cortical region BA
0.000 911 6.76 −26 33 41 Left Middle Frontal Gyrus 8
6.44 −30 50 21 Left Superior Frontal Gyrus 10
6.00 −30 22 49 Left Superior Frontal Gyrus 8
0.000 240 6.65 30 57 12 Right Superior Frontal Gyrus 10
0.000 1568 6.53 0 56 −6 Left Medial Frontal Gyrus 10
5.98 −2 48 23 Left Medial Frontal Gyrus 9
5.86 0 31 37 Left Medial Frontal Gyrus 8
0.000 521 5.91 28 26 47 Right Middle Frontal Gyrus 8
5.62 26 13 56 Right Middle Frontal Gyrus 6
0.000 254 5.51 −51 −34 18 Left Insula 13
5.00 −59 −19 10 Left Transverse Temporal Gyrus 42
0.000 278 5.51 −53 −59 21 Left Superior Temporal Gyrus 39
5.45 −48 −61 29 Left Middle Temporal Gyrus 39
0.000 269 5.47 −46 26 24 Left Middle Frontal Gyrus 46
5.27 −50 13 29 Left Inferior Frontal Gyrus 9
0.000 113 5.41 −44 21 −9 Left Inferior Frontal Gyrus 47
0.000 140 5.35 −48 0 2 Left Superior Temporal Gyrus 22
Table 5
Results of the IRCA in the Y-group: regions whose metabolism is negatively correlated with that of the cerebellar cluster of interest. IRCA: interregional correlation
analysis. Y-group: YES sport practice. BA: Brodmann Area.
P (FWEcorrected) Cluster extent Z-score Talairach coordinates Cortical region BA
0.014 393 4.83 26 41 38 Right Superior Frontal Gyrus 8
3.73 28 26 47 Right Middle Frontal Gyrus 8
0.000 877 4.19 −6 2 40 Left Cingulate Gyrus 24
4.19 2 11 31 Right Cingulate Gyrus 24
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(data not shown). The issue of the different levels of exposure to sport
practice should be considered in future studies. In the study by Visser
et al. (Visser et al., 2018) a linear association between PA and ALS was
reported: the more active a person has been, the higher the risk of
developing ALS. Otherwise, other studies suggested that PA could have
a different impact on ALS risk according to the level of exposure: a
small amount could be protective and a higher level of activity detri-
mental (Hamidou et al., 2014; Fang et al., 2016; Bandres-Ciga et al.,
2018). Finally, the age of the exposure to PA should be considered.
Indeed, PA can modulate brain plasticity (Fernandes et al., 2017), and it
is well recognized that brain plasticity in response to environmental
factors varies along the life course (Li et al., 2014;Todorova and
Blokland, 2017). As a consequence, PA might exert different effects
according to the age of exposure.
On the other hand, the present study shows some strengths. To our
knowledge, it is the first one employing neuroimaging to integrate
epidemiological data in order to assess the impact of lifetime sport
practice on the neurodegenerative process due to ALS. Second, the
exposome data have been collected without stressing specific hy-
potheses about the risk of developing the disease, limiting recall bias as
much as possible. Third, we were able to consider sport practice per se,
eliminating the influence of PA due to hobbies and occupations. Fourth,
we considered concomitant exposures (general traumas, head traumas,
sport-related drugs) that can act as possible confounders, excluding
their impact on our results. Actually, a potential impact of sport-related
drugs cannot be completely ruled out, as the use of illicit drugs may
have been under-reported by patients.
In conclusion, this is the first study about the brain metabolic cor-
relates of lifetime sport practice in ALS and suggests that patients who
never practiced sports regularly might cope better with the neurode-
generative process. Nevertheless, further studies are necessary to cor-
roborate this hypothesis. They should stratify patients according to the
age and the level of exposure to sport activity and employ more accu-
rate tools to evaluate patients’ motor performance and further imaging
techniques to estimate the damage due to neurodegeneration at dif-
ferent levels.
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